Topiramate

Topiramate

토피라메이트

중추신경계

97240-79-4

20130912-170-I-365-10(2) 20160713-170-I-472-16(1)

Bal Pharma Limited Nifty Labs Pvt.,Ltd.

USP

[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0²,⁶]dodecan-6-yl]methyl sulfamate

2,3:4,5-bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate 2,3:4,5-di-O-isopropylidene-β-D-fructopyranose sulfamate

Topiramate is a anti-epileptic drug used to manage seizures and prevent migraines. It was initially approved by the FDA in 1996. In 2004, topiramate was approved for the prevention of migraine in adults. Since 2012, the extended-release formulation has been approved in combination with   phentermine   for chronic weight management therapy in adults. Characteristics that distinguish topiramate from other antiepileptic drugs are a monosaccharide chemical structure containing a sulfamate, and 40% of its mass accounted for by oxygen. Interestingly, topiramate was discovered by chance when attempts were made to formulate a novel antidiabetic drug

If you need more information, please contact us.